Koyfin Home > Directory > Health Care > Acceleron Pharma > EV / Sales (ltm)

Acceleron Pharma EV / Sales (ltm) Chart (XLRN)

Acceleron Pharma annual/quarterly EV / Sales (ltm) from 2013 to 2020.
  • Acceleron Pharma EV / Sales (ltm) for the quarter ending September 09, 2020 was 72.73 a 4.13% increase of 3.00 year over year
  • Acceleron Pharma EV / Sales (ltm) for the last 12 months ending September 09, 2020 was 72.73 a 4.13% increase of 3.00 year over year
  • Acceleron Pharma Annual EV / Sales (ltm) for 2020 was 72.73 a -0.55% decrease of -0.40 from 2019
  • Acceleron Pharma Annual EV / Sales (ltm) for 2020 was 73.12 a 3.85% increase of 2.82 from 2019
  • Acceleron Pharma Annual EV / Sales (ltm) for 2020 was 70.31 a 0.83% increase of 0.58 from 2019
Other Valuation Metrics:
  • Acceleron Pharma Market Cap for the quarter ending March 03, 2018 was $1,776m a 33.91% increase of 602m year over year
  • Acceleron Pharma Price / Book for the quarter ending March 03, 2018 was 4.85 a -16.20% decrease of -0.78 year over year
  • Acceleron Pharma Enterprise Value for the quarter ending March 03, 2018 was $1,499m a 31.12% increase of 466m year over year
View Chart On Koyfin

Quarterly XLRN EV / Sales (ltm) Data

09/202072.73
09/202073.12
09/202070.31
09/202069.73
09/202067.60
09/202071.73
09/202070.59
09/202069.04
09/202068.65
09/202067.05

Annual XLRN EV / Sales (ltm) Data

202072.73
202073.12
202070.31
202069.73
202067.60
202071.73
202070.59
202069.04
202068.65
202067.05